Hemostasis and Tissue Sealing Agents Market Research Report - Forecast till 2030

Hemostasis and Tissue Sealing Agents Market Research Report: by Product (Topical hemostats, Mechanical), End User (Hospital, Ambulatory Centers) - Forecast Till 2030

ID: MRFR/HC/6090-HCR | February 2021 | Region: Global | 90 pages

Hemostasis Tissue Sealing Agents Market Speak to Analyst Request a Free Sample

Hemostasis and Tissue Sealing Agents Market Scenario


Hemostasis and Tissue Sealing Agents Market is expected to grow significantly and is projected to grow at a CAGR of 8.6% over the forecast period. Hemostats, adhesives and sealants are useful aides to modern surgical procedures. Topical hemostats are utilized intraoperatively first and postoperatively to a reduce extent. These products can be utilized to diffuse raw surface bleeding, bone bleeding, oozing venous type bleeds, and needle-opening bleeding. There has been increasing demand for such products as it reduces complication during surgical procedures. Moreover, large number of surgical procedures across the globe are impacting the growth of the market positively. Surgical procedures are medical interventions involving an incision with instruments usually performed in an operating theatre and normally involving various medical devices such as catheters and tubes. For instance, according to the Center for Diseases Control and Prevention, approximately 46.5 million surgical procedures are performed every year in the U.S. Additionally, according to the NHS, surgery is the most important treatment offered by the NHS in secondary care within the UK. Furthermore, in 2015, NHS estimated that there were around 4.7 million surgical admissions in England, out of which 1.3 million procedures were for general surgery and around 1.2 million procedures were for trauma and orthopedics. These high surgical procedure numbers lead to rising need for hemostasis and tissue sealing agents which reduces the risk during surgical procedures. However, factors such as increasing advancement minimally invasive procedures, lack of reimbursement for these products is hampering the growth of the market.    


Hemostasis and Tissue Sealing Agents Market Segmentation


The hemostasis and tissue sealing agents market has been segmented into product, and end user.


By product, the market has been segmented into topical hemostats, and adhesive & tissue sealant. Furthermore, topical hemostats is divided into Active, mechanical (collagen based hemostats, cellulose based hemostats, gelatin based hemostats, polysaccharide based hemostats) Flowable. Adhesive & tissue sealant is further segmented into synthetic, natural, and adhesion barrier.


Further on the basis of end user the market is bifurcated into hospitals, ambulatory centers and others


The Hemostasis and tissue sealing agents market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The diagnostics imaging workstations market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European Hemostasis and tissue sealing agents market has been segmented into Western Europe and Eastern Europe. The Western Europe diagnostics imaging workstations market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The diagnostics imaging workstations market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The diagnostics imaging services market in the Middle East & Africa has been segmented into the Middle East and Africa.


Hemostasis and Tissue Sealing Agents Market Key players


Johnson & Johnson, Cryolife, Inc., Baxter International, Inc, Ethicon LLC, Integra Lifesciences Corporation, Becton, Dickinson & Company, Cohera Medical, Inc., Pfizer, Inc, Medtronic plc, B. Braun Melsungen AG, MIL Laboratories Pvt. Ltd, Advanced Medical Solutions Group Plc


Hemostasis and Tissue Sealing Agents Regional Market Summary

Global Hemostasis and tissue sealing agents Systems Share (%), by Region, 2017


Hemostatis and Tissue Sealing Agents Market


Source: White Papers, Company Presentations, Annual Reports


Geographically, the Americas is anticipated to dominate the hemostasis and tissue sealing agents market owing to the high clinical R&D budgets by both government as well as public and private organizations, presence of major manufacturers for the products, high number of surgical procedures and various others. Europe is expected to hold the second largest position in the hemostasis and tissue sealing agents market. The Hemostasis and tissue sealing agents market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increased medical tourism for surgical procedures, increasing healthcare expenditure in developing countries and various others. The Middle East & Africa has the lowest share of the hemostasis and tissue sealing agents market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.


Hemostasis and Tissue Sealing Agents Market, by Product


  • Topical hemostats

    • Collagen Based Hemostats

    • Cellulose Based Hemostats

    • Gelatin Based Hemostats

    • Polysaccharide Based Hemostats




    • Active

    • Mechanical

    • Flowable


  • Adhesive & tissue sealant


    • Synthetic

    • Natural

    • Adhesion barrier



Hemostasis and Tissue Sealing Agents Market, by End User


  • Hospitals

  • Ambulatory Centers

  • Others


Hemostasis and Tissue Sealing Agents Market, by Region


  • Americas

    • North America

      • US

      • Canada



    • Latin America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Company Profiles



  • Johnson & Johnson

  • Cryolife, Inc.

  • Baxter International, Inc

  • Ethicon LLC

  • Integra Lifesciences Corporation

  • Becton, Dickinson & Company

  • Cohera Medical, Inc.

  • Pfizer, Inc

  • Medtronic plc

  • Braun Melsungen AG

  • MIL Laboratories Pvt. Ltd

  • Advanced Medical Solutions Group Plc

  • Others


Intended Audience



  • Hemostasis and Tissue Sealing Agents manufacturers and suppliers

  • Research and Development (R&D) Companies

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Usage Modes

  • Academic Institutes and Universities



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   8.6% (2020-2030)
  Base Year   2019
  Forecast Period   2020-2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Johnson & Johnson, Cryolife, Inc., Baxter International, Inc, Ethicon LLC, Integra Lifesciences Corporation, Becton, Dickinson & Company, Cohera Medical, Inc., Pfizer, Inc, Medtronic plc, B. Braun Melsungen AG, MIL Laboratories Pvt. Ltd, Advanced Medical Solutions Group Plc
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers   Large number of surgical procedures


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The hemostasis and tissue sealing agents market is expected to exhibit a solid 8.6% CAGR over the forecast period.

The increasing demand for minimally invasive surgical procedures is likely to be a key restraint on the hemostasis and tissue sealing agents market.

Leading players in the hemostasis and tissue sealing agents market include Cryolife, Johnson & Johnson, Becton Dickinson and Company, Pfizer, Medtronic, and Baxter, among others.